...
search icon
imvt-img

Immunovant Inc Share Price

IMVT
NSQ
$26.939
+$0.63
(2.39%)
1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.30B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
716.37K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$12.72 L
$27.69 H
$26.939

About Immunovant Inc, Common Stock

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIMVTSectorS&P500
1-Week Return1.54%1.68%0.92%
1-Month Return13.55%4.42%0.87%
3-Month Return63.67%9.42%2.47%
6-Month Return55.77%17.15%11.19%
1-Year Return11.34%12.6%16.96%
3-Year Return40.39%18.53%77.94%
5-Year Return-46.96%34.7%80.94%
10-Year Return164.42%132.46%260.32%

Financials

Mar '21Mar '22Mar '23Mar '24Mar '255YR TREND
Total Revenue-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Cost of Revenue998.00K1.23M1.32M231.00K377.00K[{"date":"2021-03-31","value":75.38,"profit":true},{"date":"2022-03-31","value":93.05,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":17.45,"profit":true},{"date":"2025-03-31","value":28.47,"profit":true}]
Gross Profit(998.00K)(1.23M)(1.32M)(231.00K)(377.00K)[{"date":"2021-03-31","value":-99800000,"profit":false},{"date":"2022-03-31","value":-123200000,"profit":false},{"date":"2023-03-31","value":-132400000,"profit":false},{"date":"2024-03-31","value":-23100000,"profit":false},{"date":"2025-03-31","value":-37700000,"profit":false}]
Gross Margin-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Operating Expenses108.12M156.03M208.28M270.21M438.15M[{"date":"2021-03-31","value":24.68,"profit":true},{"date":"2022-03-31","value":35.61,"profit":true},{"date":"2023-03-31","value":47.54,"profit":true},{"date":"2024-03-31","value":61.67,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Income(108.12M)(156.03M)(208.28M)(270.21M)(438.15M)[{"date":"2021-03-31","value":-10811700000,"profit":false},{"date":"2022-03-31","value":-15603300000,"profit":false},{"date":"2023-03-31","value":-20827600000,"profit":false},{"date":"2024-03-31","value":-27020900000,"profit":false},{"date":"2025-03-31","value":-43815200000,"profit":false}]
Total Non-Operating Income/Expense328.00K(781.00K)4.90M36.39M49.94M[{"date":"2021-03-31","value":0.66,"profit":true},{"date":"2022-03-31","value":-1.56,"profit":false},{"date":"2023-03-31","value":9.82,"profit":true},{"date":"2024-03-31","value":72.87,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Pre-Tax Income(107.79M)(156.81M)(210.95M)(258.77M)(412.95M)[{"date":"2021-03-31","value":-10778900000,"profit":false},{"date":"2022-03-31","value":-15681400000,"profit":false},{"date":"2023-03-31","value":-21095100000,"profit":false},{"date":"2024-03-31","value":-25876900000,"profit":false},{"date":"2025-03-31","value":-41294900000,"profit":false}]
Income Taxes(358.00K)(84.00K)9.00K567.00K891.00K[{"date":"2021-03-31","value":-40.18,"profit":false},{"date":"2022-03-31","value":-9.43,"profit":false},{"date":"2023-03-31","value":1.01,"profit":true},{"date":"2024-03-31","value":63.64,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes(107.43M)(156.73M)(210.96M)(259.34M)(413.84M)[{"date":"2021-03-31","value":-10743100000,"profit":false},{"date":"2022-03-31","value":-15673000000,"profit":false},{"date":"2023-03-31","value":-21096000000,"profit":false},{"date":"2024-03-31","value":-25933600000,"profit":false},{"date":"2025-03-31","value":-41384000000,"profit":false}]
Income From Continuous Operations(107.43M)(156.73M)(210.96M)(259.34M)(413.84M)[{"date":"2021-03-31","value":-10743100000,"profit":false},{"date":"2022-03-31","value":-15673000000,"profit":false},{"date":"2023-03-31","value":-21096000000,"profit":false},{"date":"2024-03-31","value":-25933600000,"profit":false},{"date":"2025-03-31","value":-41384000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income(107.43M)(156.73M)(210.96M)(259.34M)(413.84M)[{"date":"2021-03-31","value":-10743100000,"profit":false},{"date":"2022-03-31","value":-15673000000,"profit":false},{"date":"2023-03-31","value":-21096000000,"profit":false},{"date":"2024-03-31","value":-25933600000,"profit":false},{"date":"2025-03-31","value":-41384000000,"profit":false}]
EPS (Diluted)(1.24)(1.43)(1.71)(1.90)(2.74)[{"date":"2021-03-31","value":-124,"profit":false},{"date":"2022-03-31","value":-143,"profit":false},{"date":"2023-03-31","value":-171,"profit":false},{"date":"2024-03-31","value":-190,"profit":false},{"date":"2025-03-31","value":-274,"profit":false}]

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top